Clin2
NCT06001333Possibly a fitRecruiting

Fecal transplant to clear superbugs from the gut

Carbapenem-Resistant EnterobacteriaceaeVancomycin (Glycopeptide) Resistant Enterococcus (VRE)

Treatments studied

Part of Digestive system, Infections clinical trials.

This study tests whether a fecal transplant (FMT) can remove certain antibiotic-resistant bacteria from your gut. It might help people who carry superbugs like CPE or VRE but aren't currently on antibiotics.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
240 people
Ages
20 years and older
Study type
Interventional

Who can take part

  • You are 20 years or older.
  • You have tested positive for a specific superbug (CPE or VRE) from a rectal swab in the last week.
  • You are willing to have a fecal transplant and give stool samples before and after.
  • You have stopped taking antibiotics for 3 to 7 days before the procedure.
  • You are not currently on antibiotics for an infection and do not have a severe immune problem.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07525089Enrolling by invitation
Treatment to Clear Resistant Bacteria from Your Gut

This study tests whether a new treatment called BM111 can safely clear two types of antibiotic-resistant bacteria (CRE and VRE) that live in your intestines without causing infection. You'd provide stool samples over several weeks to see if the bacteria levels drop.

Seoul
NCT05035342Recruiting· Phase 3
Fecal transplant to clear resistant gut bacteria

This Phase 3 study tests whether a fecal microbiota transplant (FMT) can eliminate hard-to-treat bacteria in the gut, such as ESBL or carbapenem-resistant bacteria. If it works, it may reduce future infections and antibiotic-resistant illness.

Clichy
NCT04759001Recruiting· Phase 1/Phase 2
Fecal treatment to clear gut bacteria resistant to antibiotics

This study tests a stool-based treatment (fecal microbiota treatment) to help remove “carbapenem-resistant” bacteria living in the gut. If you carry these bacteria without being sick, the goal is to reduce or stop that colonization.

Rome
NCT05791396Recruiting· Phase 1/Phase 2
Fecal microbiome therapy to clear hard-to-treat gut germs

This trial looks at a treatment made from stool donors (called fecal microbiome therapy) to help remove carbapenem-resistant gut bacteria in the body. It’s mainly for adults who recently tested positive for these bacteria on a rectal swab, and it checks whether the therapy can help eradicate the germs.

Roma
NCT07265817Not yet recruiting
Fecal transplant for multidrug-resistant bacteria

This trial tests whether a fecal microbiota transplant (transferring healthy bacteria from a donor) can help clear multidrug-resistant bacteria from your body. It may be an option if you have such bacteria and are looking for a way to remove them.

NCT07094984Recruiting
Clearing resistant gut bacteria: three FMT methods

This trial tests three different ways to clear antibiotic-resistant bacteria from your gut using fecal microbiota transplant (FMT). It may help if you have a confirmed resistant infection and are looking for a treatment to reduce the risk of future infections.

Warsaw

Hear when a new Carbapenem-Resistant Enterobacteriaceae trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.